Scott is Professor of Medicines Discovery at the Institute for Neuroscience and Cardiovascular Research at the University of Edinburgh. He has >25 years’ experience in drug discovery and clinical development in academia and industry, working on a range of therapeutic targets and indications. He was co-founder and Chief Technology Officer of Kynos Therapeutics, a university spinout, which was recently acquired by Dr. Falk Pharma GmbH.